Shineco (SISI) Competitors

$0.96
+0.15 (+18.52%)
(As of 05/17/2024 ET)

SISI vs. SNPX, GNPX, SILO, NEXI, FWBI, SEEL, CING, FRTX, ZVSA, and PTIX

Should you be buying Shineco stock or one of its competitors? The main competitors of Shineco include Synaptogenix (SNPX), Genprex (GNPX), Silo Pharma (SILO), NexImmune (NEXI), First Wave BioPharma (FWBI), Seelos Therapeutics (SEEL), Cingulate (CING), Fresh Tracks Therapeutics (FRTX), ZyVersa Therapeutics (ZVSA), and Protagenic Therapeutics (PTIX). These companies are all part of the "medical" sector.

Shineco vs.

Synaptogenix (NASDAQ:SNPX) and Shineco (NASDAQ:SISI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

Synaptogenix has higher earnings, but lower revenue than Shineco.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SynaptogenixN/AN/A-$6.04MN/AN/A
Shineco$550K11.26-$13.36MN/AN/A

Shineco's return on equity of -18.51% beat Synaptogenix's return on equity.

Company Net Margins Return on Equity Return on Assets
SynaptogenixN/A -18.51% -14.36%
Shineco N/A -33.17%-17.42%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synaptogenix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Shineco
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

10.3% of Synaptogenix shares are owned by institutional investors. Comparatively, 4.1% of Shineco shares are owned by institutional investors. 4.3% of Synaptogenix shares are owned by insiders. Comparatively, 0.3% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Synaptogenix has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, Shineco has a beta of -0.21, indicating that its share price is 121% less volatile than the S&P 500.

Synaptogenix received 1 more outperform votes than Shineco when rated by MarketBeat users.

CompanyUnderperformOutperform
SynaptogenixOutperform Votes
1
50.00%
Underperform Votes
1
50.00%
ShinecoN/AN/A

In the previous week, Synaptogenix had 1 more articles in the media than Shineco. MarketBeat recorded 2 mentions for Synaptogenix and 1 mentions for Shineco. Shineco's average media sentiment score of 1.47 beat Synaptogenix's score of 0.75 indicating that Synaptogenix is being referred to more favorably in the media.

Company Overall Sentiment
Synaptogenix Positive
Shineco Positive

Summary

Synaptogenix beats Shineco on 9 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SISI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SISI vs. The Competition

MetricShinecoAgricultural production IndustryMedical SectorNASDAQ Exchange
Market Cap$6.19M$394.18M$5.17B$7.96B
Dividend YieldN/A4.43%44.01%3.91%
P/E RatioN/A7.29118.4515.56
Price / Sales11.263.212,367.4177.86
Price / CashN/A57.7236.4531.98
Price / Book0.061.645.754.76
Net Income-$13.36M-$21.63M$105.79M$217.17M
7 Day Performance24.30%1.50%1.39%2.90%
1 Month Performance33.33%5.60%4.28%6.57%
1 Year Performance-82.22%15.83%7.71%10.17%

Shineco Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNPX
Synaptogenix
0 of 5 stars
$4.68
-0.6%
N/A-76.8%$5.10MN/A-0.185Upcoming Earnings
News Coverage
GNPX
Genprex
4.1864 of 5 stars
$2.48
-5.0%
$10.00
+303.2%
-91.8%$5.21MN/A-0.1026Analyst Forecast
SILO
Silo Pharma
1.3133 of 5 stars
$1.71
-2.3%
$10.00
+484.8%
-3.4%$4.98M$72,102.000.003
NEXI
NexImmune
0 of 5 stars
$3.59
+2.0%
N/A-55.5%$4.92MN/A-0.1222Upcoming Earnings
Positive News
FWBI
First Wave BioPharma
1.4542 of 5 stars
$2.64
+1.5%
$118.00
+4,369.7%
-94.4%$5.35MN/A-0.019Short Interest ↑
News Coverage
SEEL
Seelos Therapeutics
1.7646 of 5 stars
$0.29
-6.4%
$70.00
+23,701.4%
-99.2%$4.89M$2.20M0.0015Stock Split
News Coverage
CING
Cingulate
2.9512 of 5 stars
$0.89
+2.3%
$8.00
+802.2%
-95.8%$5.37MN/A-0.0313
FRTX
Fresh Tracks Therapeutics
0 of 5 stars
$0.90
-3.2%
N/A+82.3%$5.38M$10.06M-0.644Gap Down
ZVSA
ZyVersa Therapeutics
2.3029 of 5 stars
$6.47
+1.3%
$120.00
+1,754.7%
-96.6%$4.86MN/A0.007News Coverage
Gap Down
PTIX
Protagenic Therapeutics
0 of 5 stars
$1.22
-2.4%
N/A-32.7%$5.42MN/A-1.06N/AUpcoming Earnings
Gap Up

Related Companies and Tools

This page (NASDAQ:SISI) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners